Pharmapack Europe has announced the winners of its newly reformatted Pharmapack Awards, recognizing excellence in six key ...

PacBio, a developer of high-quality, accurate sequencing solutions, has appointed David Ruggiero as the company’s new Global ...

Recipharm’s new modular sterile filling system, specifically tailored for process development, pilot scale and clinical ...

The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading ...

Independent research institute BioMed X has completed its oncology research project in partnership with Merck, the data from ...

4Q Earnings: $3.7 billion (loss of $1.2 billion 4Q23) FY Earnings: $17.1 billion (earnings were $365 million FY23) ...

Results include $1.2 billion of sales from rare disease products, driven by TEPEZZA, KRYSTEXXA, UPLIZNA, and TAVNEOS. Earnings reflect acquisition-related costs related to the Horizon acquisition.

New kits are designed to offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes.

Trilobio, developer of whole lab automation systems for biology research, introduced the first version of its comprehensive robotics, lab equipment and software platform.

Comments: Growth in the quarter was driven by Mounjaro, with sales up 60% to $3.5 billion, and Zepbound, with sales of $1.9 billion. New Products revenue, which consists of Ebglyss, Jaypirca, Kisunla, ...

After thirteen years with Carbogen Amcis, the last three of which he served as Chief Executive Officer (CEO), Pascal ...

Affinia Therapeutics, a gene therapy company with a pipeline of adeno-associated virus (AAV) gene therapies for devastating ...